Livia Lamartina
Overview
Explore the profile of Livia Lamartina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haissaguerre M, Groussin L, Lamartina L, Buffet C, Caron P
Ann Endocrinol (Paris)
. 2025 Feb;
86(2):101707.
PMID: 39909103
No abstract available.
2.
Baudin E, Hadoux J, Berruti A, Lamartina L, Texier M, Fassnacht M
Lancet
. 2025 Feb;
405(10476):381-382.
PMID: 39892908
No abstract available.
3.
Kanaan C, Bani M, Ducreux M, Planchard D, Lamartina L, Moog S, et al.
Virchows Arch
. 2024 Dec;
PMID: 39671088
The double inactivation of TP53 and RB1 is considered typical of neuroendocrine carcinomas (NECs) but is assumed to be rare in high-grade neuroendocrine tumors (NETs). The immunohistochemical determination of the...
4.
Leboulleux S, Bournaud C, Chougnet C, Lamartina L, Zerdoud S, Do Cao C, et al.
Lancet Diabetes Endocrinol
. 2024 Nov;
13(1):38-46.
PMID: 39586309
Background: ESTIMABL2, a multicentre randomised phase 3 trial in patients with low-risk differentiated thyroid cancer (ie, pT1am or pT1b, N0 [no evidence of regional nodal involvement] or Nx [involvement of...
5.
Bani M, Moog S, Suciu V, Lamartina L, Al Ghuzlan A
Bull Cancer
. 2024 Nov;
111(10S1):10S5-10S18.
PMID: 39505436
WHO CLASSIFICATION 2022, BETHESDA SYSTEM 2023, MOLECULAR BIOLOGY AND MOLECULAR TESTING: Thyroid pathology has experienced significant advances with the publication of the 5th edition of the World Health Organization classification...
6.
Lamartina L, Grunenwald S, Roy M, Hartl D, Buffet C
Bull Cancer
. 2024 Nov;
111(10S1):10S19-10S30.
PMID: 39505432
The incidence of follicular-derived thyroid cancers has increased worldwide in recent decades, mainly papillary thyroid cancers at low recurrence risk. A process of de-escalation in the initial management and follow-up...
7.
Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, et al.
Lancet
. 2024 Feb;
403(10431):1061-1070.
PMID: 38402886
Background: No randomised controlled trial has ever been done in patients with metastatic phaeochromocytomas and paragangliomas. Preclinical and first clinical evidence suggested beneficial effects of sunitinib. We aimed to evaluate...
8.
Haissaguerre M, Lamartina L, Caron P
Ann Endocrinol (Paris)
. 2024 Feb;
85(2):155-157.
PMID: 38336563
No abstract available.
9.
Aksoy Y, Xu B, Viswanathan K, Ahadi M, Al Ghuzlan A, Alzumaili B, et al.
Histopathology
. 2024 Jan;
84(6):947-959.
PMID: 38253940
Aims: Recently, there have been attempts to improve prognostication and therefore better guide treatment for patients with medullary thyroid carcinoma (MTC). In 2022, the International MTC Grading System (IMTCGS) was...
10.
Guerlain J, Breuskin I, Abbaci M, Lamartina L, Hadoux J, Baudin E, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201609
Hypoparathyroidism is the most frequent complication in thyroid surgery. The aim of this study was to evaluate the impact of intraoperative parathyroid gland identification, using autofluorescence imaging, on the rate...